TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Drug Overdose/drug therapy
KW - Humans
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Ontario
KW - Opioid-Related Disorders/drug therapy
KW - Pharmacies
KW - policy
KW - Drug policy
KW - Harm Reduction
KW - Health Services Research
KW - naloxone
KW - Opioid
KW - policy evaluation
AU - T. Antoniou
AU - D. Martins
AU - T. Campbell
AU - M. Tadrous
AU - C. Munro
AU - P. Leece
AU - M. Mamdani
AU - D. N. Juurlink
AU - T. Gomes
A1 - 
AD - Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Unity Health, Toronto, Ontario, Canada.; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Women's College Hospital, Toronto, Ontario, Canada.; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.; Ontario Drug Policy Research Network Lived Experience Advisory Group, Toronto, Ontario, Canada.; Public Health Ontario, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; The Sunnybrook Research Institute, Toronto, Canada.; Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
BT - Addiction (Abingdon, England)
C5 - Education & Workforce; Opioids & Substance Use
CP - 6
DO - 10.1111/add.15324
IS - 6
JF - Addiction (Abingdon, England)
LA - eng
M1 - Journal Article
PB - Her Majesty the Queen in Right of Canada. Addiction published by John Wiley & Sons Ltd on behalf of the Society for the Study of Addiction
PY - 2021
SN - 1360-0443; 0965-2140; 0965-2140
SP - 1514
EP - 1520
EP - 
T1 - Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis
T2 - Addiction (Abingdon, England)
TI - Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis
U1 - Education & Workforce; Opioids & Substance Use
U2 - 33207025
U3 - 10.1111/add.15324
VL - 116
VO - 1360-0443; 0965-2140; 0965-2140
Y1 - 2021
Y2 - Jun
ER -